𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans I: Pharmacokinetics

✍ Scribed by Peter H. Hinderling; Ursula Gundert-Remy; Olga Schmidlin


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
864 KB
Volume
74
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Integrated pharmacokinetics and pharmaco
✍ Peter H. Hinderling; Ursula Gundert-Remy; Olga Schmidliny; GΓΌnther Heinzel πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 829 KB

This study determined the kinetics of the effects of atropine on heart rate and saliva flow in three healthy male volunteers after intravenous administration of 1.35 and 2.15 mg of the drug. The pharmacokinetics of atropine and its primary metabolite, tropine, were determined simultaneously. Both th

Pharmacokinetics and pharmacodynamics of
✍ Capecchi, Pier Leopoldo; Blardi, Patrizia; De Lalla, Arianna; Ceccatelli, Linda; πŸ“‚ Article πŸ“… 1995 πŸ› Nature Publishing Group 🌐 English βš– 865 KB

Object&e: To study the possibility that the penetration of the antibiotic ciprofloxacin into polymorphonuclear leukocytes (PMN) may be associated with some changes in cell reactivity. Design: Superoxide anion and chemkminescence generation induced by formyl-methionyl-leucylphenylalanine (fMLP) and p

Pharmacokinetics, pharmacodynamics and d
✍ Al-Ghananeem, Abeer M. (author) πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons Inc. 🌐 English βš– 170 KB

The objective of this study was to characterize the clinical pharmacokinetic profile of lofexidine after oral delivery. A single dose, cross-over study and a multidose study using healthy volunteers were conducted for that purpose. In the single dose study the average time to maximum concentration w

A review of the pharmacokinetics, tolera
✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine